Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,137.88 -22.43 -1.04%
FTSE 100 5,331.16 -59.98 -1.11%
DAX 6,334.48 -62.36 -0.97%
Ticker Volume Price Price Delta
Nikkei 8,633.19 -23.89 -0.28%
TOPIX 723.62 -3.41 -0.47%
Hang Seng 18,690.20 -365.24 -1.92%
Gold 1,549.90 -0.07%
EUR-USD 1.2451 -0.4133%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,331.16 -1.11%
STOXX 50 2,137.88 -1.04%
DAX 6,334.48 -0.97%
Oil (WTI) 89.85 -1.00%
U.S. 10-year 1.709% -0.036
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Exchange: SIX Swiss Ex
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Roche Holding AG

Add to Portfolio

ROG:VX

151.800 CHF 0.800 0.52%

As of 04:11:37 ET on 05/30/2012.

Snapshot for Roche Holding AG (ROG)

Open: 152.100 Day's Range: 151.700 - 152.300 Volume: 152,708 Bid: 151.800
Previous Close: 152.600 52wk Range: 115.100 - 169.200 1-Yr Rtn: +7.72% Ask: 151.900

Stock Chart for ROG

No chart data available.
  • ROG:VX 151.800
  • 1D
  • 1M
  • 1Y
152.600
Interactive ROG Chart

Previous Close

Key Statistics for ROG

Current P/E Ratio (ttm) 13.7875
Estimated P/E (12/2012) 11.1331
Earnings Per Share (CHF) (ttm) 11.0100
Est. EPS (CHF) (12/2012) 13.6350
Est. PEG Ratio 1.5226
Market Cap (M CHF) 132,201.02
Shares Outstanding (M) 702.56
Enterprise Value (M CHF) (ttm) 150,154.02
Enterprise Value/EBITDA (ttm) 9.49
Price/Book (mrq) 10.8257
Price/Sale (ttm) 3.0320
Dividend Indicated Gross Yield 4.4796
Next Earnings Announcement 07/26/2012
More ROG Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for ROG

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)
More ROG Income Statement Data
  • Total Assets
  • Total Liabilities (M/CHF)
  • Debt to Assets (%)
More ROG Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/CHF)
More ROG Cash Flow Data

Company Profile & Key Executives for ROG

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Franz B HumerChairmanBruno GehrigVice Chairman
Andre Serenus HoffmannVice ChairmanSeverin SchwanChief Executive Officer
More Company Profile & Key Executives for ROG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements